Ajanta Pharma announces launch of migraine drug in US
Indian pharmaceutical company Ajanta Pharma Limited has announced the launch of Eletriptan Hydrobromide tablets (20 mg and 40 mg) in […]
Indian pharmaceutical company Ajanta Pharma Limited has announced the launch of Eletriptan Hydrobromide tablets (20 mg and 40 mg) in […]
Indian pharmaceutical major Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to […]
Arthritis sufferers who take the drug ibuprofen for pain relief are at greater risk of high blood pressure, heart disease […]
Pharma major Zydus Cadila on Wednesday announced to have received USFDA nod to market Tiadylt ER capsule and Azelastine Hydrochlorid […]
Drug firm Lupin has received FDA approval to market Nikita aka Pitavastatin tablets ”used for lowering bad cholesterol levels, available in […]
The Drug Controller General of India (DCGI) has given a green signal to global pharma firm Mylan for marketing its […]
Glenmark Pharmaceuticals has received the final ANDA approval from the United States Food and Drug Administration (USFDA) to market Acyclovir […]
Alembic Pharmaceuticals Limited on Monday announced that it has received approval from the US Food and Drug Administration (USFDA) for […]
US Food and Drug Administration (FDA) has given its nod to Indian pharmaceutical major Zydus Cadila for manufacturing of Mesalamine […]
Indian pharmaceutical company Natco Pharma Limited has received successful Establishment Inspection Report (EIR) from the US Food and Drug Administration […]
India has been doing exceptionally well in the pharmaceutical sector for the last 20-25 years, but since the country agreed […]
Glenmark Pharmaceuticals on Friday announced that the leading research“based global pharmaceutical company has been granted final Abbreviated New Drug Application […]
Jubilant Pharma Limited, a subsidiary of Noida-based Jubilant Life Sciences Ltd, has received Abbreviated New Drug Application (ANDA) final approval […]